| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Canine distemper - adenovirus type 2 - parainfluenza - parvovirus vaccine - leptospira bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bordetella bronchiseptica - erysipelothrix rhusiopathiae - pasteurella multocida bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Avian reovirus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Vibrio anguillarum - salmonicida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Clostridium chauvoei - septicum - novyi - sordellii bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bordetella bronchiseptica - escherichia coli bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis vaccine - haemophilus somnus - pasteurella haemolytica - multocida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Borrelia burgdorferi bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Polyvalent snake antivenin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis - virus diarrhea vaccine - haemophilus somnus leptospira pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Clostridium perfringens type D bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Clostridium chauvoei - septicum bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Animal disease vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bordetella bronchiseptica - erysipelothrix rhusiopathiae bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bursal disease - Newcastle disease - bronchitis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Product containing Erysipelothrix rhusiopathiae antiserum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Duck virus hepatitis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Mycobacterium paratuberculosis bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Clostridium perfringens type C bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Therapeutic vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Actinobacillus pleuropneumoniae - pasteurella multocida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Marek's disease vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Campylobacter fetus - chlamydia psittaci bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis - virus diarrhea - parainfluenza 3 - respiratory syncytial virus vaccine - pasteurella haemolytica bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Feline leukemia vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Salmonella typhimurium bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Erysipelothrix rhusiopathiae - pasteurella multocida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bordetella bronchiseptica vaccine - pasteurella multocida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Product containing Salmonella typhimurium antiserum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis - virus diarrhea - parainfluenza 3 vaccine - haemophilus somnus - pasteurella haemolytica - multocida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bordetella bronchiseptica - escherichia coli - pasteurella multocida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine virus diarrhea vaccine - leptospira pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Escherichia coli - pasteurella multocida - salmonella choleraesuis bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| anticorps monoclonal contre Escherichia coli |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis - virus diarrhea - parainfluenza 3 vaccine - haemophilus somnus - campylobacter fetus - leptospira canicola- grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Haemophilus somnus bacterial extract |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Escherichia coli bacterial extract |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Chlamydia psittaci bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bursal disease - Newcastle disease vaccine - pasteurella multocida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Salmonella choleraesuis bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Actinobacillus pleuropneumoniae - streptococcus suis bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Canine lymphoma monoclonal antibody |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Clostridium chauvoei - septicum - pasteurella haemolytica - multocida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bordetella avium bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Brucella abortus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Pasteurella haemolytica - multocida vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Transmissible gastroenteritis immunity inducer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Mycoplasma hyopneumoniae bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Erysipelothrix rhusiopathiae vaccine - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis vaccine - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine immunoglobulin G preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bursal disease - Newcastle disease - reovirus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| C & D bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Mycobacterium cell wall immunostimulant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bacteroides nodosus bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Trichomonas foetus bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Pseudomonas aeruginosa bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Canine distemper - adenovirus type 2 - coronavirus - parainfluenza - parvovirus vaccine - leptospira bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Campylobacter fetus - leptospira pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Pasteurella multocida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Haemophilus somnus bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Product containing Streptococcus equisimilis antiserum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| lactosérum colostral normal |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Erysipelothrix rhusiopathiae bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| encephalomyelitis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Newcastle disease - avian encephalomyelitis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Transmissible gastroenteritis vaccine - clostridium perfringens type C - escherichia coli bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| anaplasmosis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis - virus diarrhea - parainfluenza 3 vaccine - leptospira grippotyphosa - hardjo - pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Clostridium perfringens types C & D tetanus toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Fowl pox - Marek's disease vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Equine viral arteritis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Canine parainfluenza vaccine - bordetella bronchiseptica bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Clostridium perfringens type C antitoxin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Yersinia ruckeri bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Product containing Streptococcus suis antiserum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bursal disease - Newcastle - bronchitis - reovirus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis - virus diarrhea - parainfluenza 3-respiratory syncytial virus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Pasteurella anatipestifer bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Equine rhinopneumonitis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| bluetongue vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Staphylococcus aureus phage lysate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Flea antigen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Avian encephalomyelitis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| anatoxine tétanique, vaccin contre l'influenza et contre l'encéphalomyélite |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Corynebacterium pyogenes - pasteurella multocida antiserum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis - virus diarrhea vaccine - haemophilus somnus pasteurella haemolytica - multocida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Clostridium haemolyticum - novyi bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bordetella bronchiseptica vaccine - erysipelothrix rhusiopathiae - pasteurella multocida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Canine distemper - adenovirus type 2 - parainfluenza vaccine - leptospira bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| transmissible gastroenteritis vaccine - escherichia coli bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis - parainfluenza 3 vaccine - pasteurella haemolytica - multocida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Antitoxin (animal) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis - virus diarrhea - parainfluenza 3 vaccine - pasteurella haemolytica - multocida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Clostridium perfringens types C & D bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Autogenous bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis - parainfluenza 3 vaccine - haemophilus somnus - pasteurella haemolytica - multocida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis - virus diarrhea - parainfluenza 3 vaccine - campylobacter fetus - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Salmonella arizonae bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Mycoplasma gallisepticum bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Clostridium chauvoei - septicum - novyi - sordellii - pasteurella haemolytica - multocida bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]